The U.S. vaccine supply [4] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 10, 2005, Pages 1046-1047

  Hinman, Alan R ^a   Schwartz, Harry K ^b   Sloan, Frank A ^c   Chalk, Rosemary A ^d   Giffin, Robert B ^d  

^a Task Force for Child Survival and Development   (United States)

^b Duke University ^*  (United States)

^c DUKE UNIVERSITY   (United States)

^d NATIONAL ACADEMIES OF SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

BUDGET; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG MARKETING; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH PROGRAM; LETTER; PRIORITY JOURNAL; PROFIT; UNITED STATES; VACCINE PRODUCTION; ECONOMICS; HUMAN; LEGAL ASPECT; NOTE; ORGANIZATION AND MANAGEMENT; GOVERNMENT REGULATION; PREVENTIVE HEALTH SERVICE; REIMBURSEMENT;

DRUG INDUSTRY; FINANCING, GOVERNMENT; HUMANS; PRIVATE SECTOR; PUBLIC SECTOR; UNITED STATES; VACCINES; GOVERNMENT REGULATION; IMMUNIZATION PROGRAMS; INSURANCE, HEALTH, REIMBURSEMENT;

EID: 14744278618     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200503103521020     Document Type: Letter

References (0)